Natamycin solid lipid nanoparticles – sustained ocular delivery system of higher corneal penetration against deep fungal keratitis: preparation and optimization

References

• WongT-YNgT-PFongK-SRisk factors and clinical outcomes between fungal and bacterial keratitis: a comparative studyCLAO J19972342752819348453
   PubMedGoogle Scholar
• SharmaNChackoJVelpandianTComparative evaluation of topical versus intrastromal voriconazole as an adjunct to natamycin in recalcitrant fungal keratitisOphthalmology2013120467768110.1016/j.ophtha.2012.09.02323246119
   PubMed Web of Science ®Google Scholar
• ElshiekHPinedaRFungal keratitisAl-Basar Int J Ophthalmol20153110.4103/1858-6538.169310
   Google Scholar
• AnsariZMillerDGalorACurrent thoughts in fungal keratitis: diagnosis and treatmentCurr Fungal Infect Rep20137320921810.1007/s12281-013-0150-110.1007/s12281-013-0150-124040467
   PubMedGoogle Scholar
• SahaSBanerjeeDKhetanAEpidemiological profile of fungal keratitis in urban population of West Bengal, IndiaOman J Ophthalmol20092311410.4103/0974-620X.5731020927207
   PubMedGoogle Scholar
• SrinivasanMMascarenhasJPrashanthCDistinguishing infective versus noninfective keratitisIndian J Ophthalmol200856320310.4103/0301-4738.4035818417820
   PubMedGoogle Scholar
• BiswasNRVermaKGuptaSKAntifungal drugs for ophthalmic useGuptaAKKrishnaVClinical Ophthalmology-Contemporary Perspectives9th edIndia200996104
   Google Scholar
• QiuSZhaoG-QLinJNatamycin in the treatment of fungal keratitis: a systematic review and Meta-analysisInt J Ophthalmol20158359726086015
   PubMedGoogle Scholar
• American Academy of OphthalmologyFungal Keratitis – Latin AmericaAmerican Academy of Ophthalmology1012014 Available from: www.aao.org/topic-detail/fungal-keratitis-latinamericaAccessed May 12, 2017
   Google Scholar
• MüllerGGKara-JoséNCastroRAntifungals in eye infections: drugs and routes of administrationRev Bras Oftalmol201372213214110.1590/S0034-72802013000200014
   Google Scholar
• DongXQianTGaoWThe mechanism of action and research methods of natamycin and polyene antimycoticsChin J Mod Appl Pharm20102710878882
   Google Scholar
• KoontzJLMarcyJEBarbeauWEStability of natamycin and its cyclodextrin inclusion complexes in aqueous solutionJ Agric Food Chem200351247111711410.1021/jf030333q14611180
   PubMedGoogle Scholar
• RemingtonLAClinical Anatomy of the Visual System E-BookPA, USAElsevier Health Sciences2011
   Google Scholar
• PatelACholkarKAgrahariVOcular drug delivery systems: an overviewWorld J Pharmacol2013224710.5497/wjp.v2.i2.4725590022
   PubMedGoogle Scholar
• GaudanaRAnanthulaHKParenkyAOcular drug deliveryAAPS J201012334836010.1208/s12248-010-9183-320437123
   PubMed Web of Science ®Google Scholar
• AgrahariVMandalAAgrahariVA comprehensive insight on ocular pharmacokineticsDrug Deliv Transl Res20166673575410.1007/s13346-016-0339-227798766
   PubMed Web of Science ®Google Scholar
• AchouriDAlhanoutKPiccerellePRecent advances in ocular drug deliveryDrug Dev Ind Pharm201339111599161710.3109/03639045.2012.73651523153114
   PubMed Web of Science ®Google Scholar
• YellepeddiVKPalakurthiSRecent advances in topical ocular drug deliveryJ Ocul Pharmacol Ther2016322678210.1089/jop.2015.004726666398
   PubMed Web of Science ®Google Scholar
• DubaldMBourgeoisSAndrieuVOphthalmic drug delivery systems for antibiotherapy – a reviewPharmaceutics20181011010.3390/pharmaceutics10010010
   PubMed Web of Science ®Google Scholar
• NagarwalRCKantSSinghPPolymeric nanoparticulate system: a potential approach for ocular drug deliveryJ Control Release2009136121310.1016/j.jconrel.2008.12.01819331856
   PubMed Web of Science ®Google Scholar
• KammariRDasNGDasSKNanoparticulate systems for therapeutic and diagnostic applicationsEmerging Nanotechnologies for Diagnostics, Drug Delivery and Medical DevicesMitraAKCholkarKMandalAPA, USAElsevier2017105144
   Google Scholar
• RamDTDebnathSBabuMNA review on solid lipid nanopar-ticlesRes J Pharm Technol20125112
   Google Scholar
• MishraDDhoteVPradyumnaMSolid lipid nanoparticles: a promising colloidal carrierChourasiaMKChaurasiaMJainNKNovel Carriers for Drug DeliveryWarszawa, PolandPharmaMed Press2014278301
   Google Scholar
• SinghAUbraneRPrasadPPreparation and characterization of rizatriptan benzoate loaded solid lipid nanoparticles for brain targetingMater Today Proc2015294521454310.1016/j.matpr.2015.10.067
   Google Scholar
• El-SalamouniNSFaridRMEl-KamelAHEffect of sterilization on the physical stability of brimonidine-loaded solid lipid nanoparticles and nanostructured lipid carriersInt J Pharm2015496297698310.1016/j.ijpharm.2015.10.04326498372
   PubMed Web of Science ®Google Scholar
• KhamesAPreparation and characterization of sildenafil loaded solid lipid nanoparticles: drug delivery system suitable for nebulization ahmed khamesDer Pharmacia Lettre21079398112
   Google Scholar
• PatilALakhaniPTaskarPFormulation development, optimization, and in vitro–in vivo characterization of natamycin-loaded pegylated nano-lipid carriers for ocular applicationsJ Pharm Sci201810782160217110.1016/j.xphs.2018.04.01429698725
   PubMedGoogle Scholar
• JoshiMPatravaleVFormulation and evaluation of nanostructured lipid carrier (NLC)–based gel of ValdecoxibDrug Dev Ind Pharm200632891191810.1080/0363904060081467616954103
   PubMed Web of Science ®Google Scholar
• ThangabalanBKumarPVAnalytical method development and validation of Natamycin in eye drop by RP-HPLCAsian J Pharm Clin Res20136134135
   Google Scholar
• BattagliaLSGallarateMPancianiPTechniques for the Preparation of Solid Lipid Nano and MicroparticlesApplication of Nanotechnology in Drug DeliveryLondon, UKIntechOpen2014 Available from: https://www.intechopen.com/books/application-of-nanotechnology-in-drug-delivery/techniques-for-the-preparation-of-solid-lipid-nano-and-microparticles [online]Accessed July 6, 2018
   Google Scholar
• BaranowskiPKarolewiczBGajdaMOphthalmic drug dosage forms: characterisation and research methodsSci World J2014201414
   Google Scholar
• SatyaDSuriaKMuthuPAdvanced approaches and evaluation of ocular drug delivery systemAm J Pharmtech Res2011147292
   Google Scholar
• HaoJFangXZhouYDevelopment and optimization of solid lipid nanoparticle formulation for ophthalmic delivery of chloram-phenicol using a Box-Behnken designInt J Nanomedicine2011668310.2147/IJN.S2564621556343
   PubMed Web of Science ®Google Scholar
• El-BadawyMFTawakolWMEl-FarSWMolecular identification of aminoglycoside-modifying enzymes and plasmid-mediated qui-nolone resistance genes among Klebsiella pneumoniae clinical isolates recovered from Egyptian patientsInt J Microbiol2017201712
   Google Scholar
• DaveVPaliwalSA novel approach to formulation factor of ace-clofenac eye drops efficiency evaluation based on physicochemical characteristics of in vitro and in vivo permeationSaudi Pharm J201422324024510.1016/j.jsps.2013.03.00125061410
   PubMed Web of Science ®Google Scholar
• Rojas GómezRRestrepo ValenciaPIn vitro-in vivo Pharmacokinetic correlation model for quality assurance of antiretroviral drugsColomb Méd201546310911626600625
   PubMedGoogle Scholar
• PuranikKTagalpallewarAVoriconazole in situ gel for ocular drug deliverySOJ Pharm Pharm Sci20152211010.15226/2374-6866/2/2/00128
   Google Scholar
• VivekKReddyHMurthyRSInvestigations of the effect of the lipid matrix on drug entrapment, in vitro release, and physical stability of olanzapine-loaded solid lipid nanoparticlesAAPS Pharm Sci Tech200784162410.1208/pt0801016
   PubMed Web of Science ®Google Scholar
• MüllerRHMaèderKGohlaSSolid lipid nanoparticles (SLN) for controlled drug delivery a review of the state of the artEur J Pharm Biopharm200050116117710840199
   PubMed Web of Science ®Google Scholar
• Abd-ElbaryATadrosMIAlaa-EldinAASucrose stearate-enriched lipid matrix tablets of etodolac: modulation of drug release, diffusional modeling and structure elucidation studiesAAPS Pharm Sci Tech201314265666810.1208/s12249-013-9951-3
   PubMed Web of Science ®Google Scholar
• NanoComposixZeta potential analysis of nanoparticles20121116 Available from: https://cdn.shopify.com/s/files/1/0257/8237/files/nano-Composix_Guidelines_for_Zeta_Potential_Analysis_of_Nanoparticles.pdfAccessed August 12, 2018
   Google Scholar
• BahariLASHamishehkarHThe impact of variables on particle size of solid lipid nanoparticles and nanostructured lipid carriers; a comparative literature reviewAdv Pharm Bull20166214310.15171/apb.2016.02127478775
   PubMed Web of Science ®Google Scholar
• RoweRCSheskeyPJOwenSCHandbook of Pharmaceutical Excipients6LondonPharmaceutical press2006
   Google Scholar
• MontgomeryDCDesign and Analysis of Experiments9th edHoboken (NJ)John Wiley & Sons, Inc2017 Available from: https://www.wiley.com/en-us/Design+and+Analysis+of+Experiments%2C+9th+Edition-p-9781119113478 [online]Accessed June 17, 2018
   Google Scholar
• ThakkarHPDesaiJLParmarMPApplication of Box–Behnken design for optimization of formulation parameters for nanostructured lipid carriers of candesartan cilexetilAsian J Pharm201482
   Google Scholar
• TanvirSQiaoLSurface tension of nanofluid-type fuels containing suspended nanomaterialsNanoscale Res Lett20127122610.1186/1556-276X-7-22622513039
   PubMedGoogle Scholar
• LiXLinXZhengLEffect of poly (ethylene glycol) stearate on the phase behavior of monocaprate/Tween80/water system and characterization of poly (ethylene glycol) stearate-modified solid lipid nanoparticlesColloids Surf A Physicochem Eng Asp20083171–335235910.1016/j.colsurfa.2007.11.011
   Google Scholar
• SeyfoddinAShawJAl-KassasRSolid lipid nanoparticles for ocular drug deliveryDrug Deliv201017746748910.3109/10717544.2010.48325720491540
   PubMed Web of Science ®Google Scholar
• SawantKKDodiyaSSRecent advances and patents on solid lipid nanoparticlesRecent Pat Drug Deliv Formul20082212013510.2174/18722110878453408119075903
   PubMedGoogle Scholar
• Barzegar-JalaliMAdibkiaKValizadehHKinetic analysis of drug release from nanoparticlesJ Pharm Pharm Sci200811116717718471378
   PubMed Web of Science ®Google Scholar
• PeppasNASahlinJJA simple equation for the description of solute release. III. Coupling of diffusion and relaxationInt J Pharm198957216917210.1016/0378-5173(89)90306-2
   Web of Science ®Google Scholar
• CevherEŞensoyDZlohMPreparation and characterisation of natamycin: γ-cyclodextrin inclusion complex and its evaluation in vaginal mucoadhesive formulationsJ Pharm Sci200897104319433510.1002/jps.2131218288724
   PubMedGoogle Scholar